BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gu XQ, Zheng WP, Teng DH, Sun JS, Zheng H. Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients. World J Gastroenterol 2016; 22(9): 2749-2759 [PMID: 26973413 DOI: 10.3748/wjg.v22.i9.2749]
URL: https://www.wjgnet.com/1948-5182/full/v22/i9/2749.htm
Number Citing Articles
1
Yu Zhu, Lingling Gu, Ting Chen, Guoqun Zheng, Chao Ye, Weidong Jia. Factors influencing early recurrence of hepatocellular carcinoma after curative resectionJournal of International Medical Research 2020; 48(8): 030006052094555 doi: 10.1177/0300060520945552
2
Sascha Vaghiri, Dimitrios Prassas, Onur Mustafov, Sinan Kalmuk, Wolfram Trudo Knoefel, Nadja Lehwald-Tywuschik, Andrea Alexander, Levent Dizdar. Which factors predict tumor recurrence and survival after curative hepatectomy in hepatocellular carcinoma? Results from a European institutionBMC Surgery 2024; 24(1) doi: 10.1186/s12893-024-02399-y
3
Rahul Kakodkar. Inappropriate inferences from registry data: Pitfalls of inaccurate data handling? Indian Journal of Gastroenterology 2017; 36(2): 77 doi: 10.1007/s12664-017-0749-1
4
Xiu-Tao Fu, Ying-Hong Shi, Jian Zhou, Yuan-Fei Peng, Wei-Ren Liu, Guo-Ming Shi, Qiang Gao, Xiao-Ying Wang, Kang Song, Jia Fan, Zhen-Bin Ding. Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinomaInfectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0137-6
5
Gonzalo Sapisochin, Jordi Bruix. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approachesNature Reviews Gastroenterology & Hepatology 2017; 14(4): 203 doi: 10.1038/nrgastro.2016.193
6
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Katharina Müller, Helmut Friess, Katharina Thrum. The role of preoperative albumin‐bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinomaJournal of Surgical Oncology 2019; 120(7): 1126 doi: 10.1002/jso.25721
7
Tao Wang, Fei Tang, Fenghui Li, Weili Yin, Jing Liang. Retreatment with immunotherapy in a patient with hepatocellular carcinoma who received immune checkpoint inhibitors after primary curative treatment: a case reportFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1321195
8
LIANG LIU, PING JI, NING QU, WEI-LIN PU, DAO-WEN JIANG, WEI-YAN LIU, YA-QI LI, RONG-LIANG SHI. The impact of high co-expression of Sp1 and HIF1α on prognosis of patients with hepatocellular cancerOncology Letters 2016; 12(1): 504 doi: 10.3892/ol.2016.4634
9
M. Bina Possatto, E.C. de Ataíde, C.A. Fazzio Escanhoela, T. Sevá-Pereira, R. de Cassia Martins Alves da Silva, H. Felicio, L.R. de Navarro Amado, R. Ferreira da Silva, A. Soares Lima, I.F.S.F. Boin. Factors Related to Hepatocellular Carcinoma Recurrence After Liver Transplantation—A Brazilian Multicenter StudyTransplantation Proceedings 2017; 49(4): 863 doi: 10.1016/j.transproceed.2017.01.055
10
Walaa Abdelhamed, Mohamed El-Kassas. Hepatocellular carcinoma recurrence: Predictors and managementLiver Research 2023; 7(4): 321 doi: 10.1016/j.livres.2023.11.004